In patients with lung cancer, however, anti–PD-L1 monotherapy without subsequent steroid administration was associated paradoxically with increased survival compared with patients receiving steroids for irAEs (eFigure 11B in Supplement 1). The gene discussed is CD274; the disease is lung carcinoma.